EIX vs STRO
Edison International (EIX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EIX and STRO stock pages for the full models.
Not investment advice.